ELGX - Endologix, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Endologix, Inc.

2 Musick
Irvine, CA 92618
United States
949-595-7200
http://endologix.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full-time employees528

Key executives

NameTitlePayExercisedYear born
Mr. John OnopchenkoCEO & Director1.3MN/A1959
Mr. Vaseem MahboobChief Financial Officer1.06MN/A1969
Mr. Jeremy B. HaydenGen. Counsel944.67kN/A1970
Dr. Matthew ThompsonChief Medical Officer1.06MN/A1962
Mr. Jeffrey S. BrownChief Operations OfficerN/AN/AN/A
Amounts are as of 31 December 2018, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.

Corporate governance

Endologix, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.